RonaldEugeneGressMD

Oncology • Bethesda, MD

Chief, Experimental Transplantation and Immunology Branch, CCR, NCI, NIH

Join to view full profile

Dr. Gress is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gress' full profile

Already have an account?

Office
9000 Rockville Pike
Bethesda, MD 20892
Is this information wrong?

Education & Training

Baylor College of MedicineClass of 1975

Certifications & Licensure

MD State Medical License 1978 - 2024
TX State Medical License 1975 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1991
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer Start of enrollment: 1996 Jul 12
Completed
Phase 1
Genetic Analysis of Brain Tumors Start of enrollment: 2002 Mar 01
Terminated
Interleukin-7 in Treating Patients With Refractory Solid Tumors Start of enrollment: 2003 Apr 01
Completed
Phase 1
Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies Start of enrollment: 2003 Mar 06
Completed
Montelukast to Treat Bronchiolitis Obliterans Start of enrollment: 2008 Jun 17
Completed
Phase 2
Autologous and Related Allogeneic Hematopoietic Stem Cell Transplant Data Submission to the Center for International Blood and Marrow Transplant Research (CIBMTR) and the National Marrow Donor Program (NMDP) Start of enrollment: 2008 Dec 01
Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2010 Jan 19
Terminated
Phase 2
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2011 Mar 30
Terminated
Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation Start of enrollment: 2011 Apr 19
Completed
Phase 2
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy Start of enrollment: 2011 Apr 01
Terminated
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Providing Access to Cord Blood Units for Transplants Start of enrollment: 2011 Oct 27
Withdrawn
Phase 2
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma Start of enrollment: 2012 Jul 01
Terminated
Phase 1, Phase 2
Vaccine Response With NT-I7 Start of enrollment: 2023 May 30
Withdrawn
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Microbial ligand-independent regulation of lymphopoiesis by NOD1.
Chiaki Iwamura, Hidetaka Ohnuki, Francis A Flomerfelt, Lixin Zheng, Alexie Carletti, Hidefumi Wakashin, Yohei Mikami, Stephen R Brooks, Yuka Kanno, Ronald E Gress, Gio...> ;Nature Immunology. 2023 Dec 1
1 citations
In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water.
Jeffrey R Brender, Julian C Assmann, Don E Farthing, Keita Saito, Shun Kishimoto, Kathrynne A Warrick, Natella Maglakelidze, Terri L Larus, Hellmut Merkle, Ronald E Gr...> ;Scientific Reports. 2023 Sep 7
7 citations
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Sencer Goklemez, Sarfaraz Hasni, Frances T Hakim, Paolo A Muraro, Filip Pirsl, Jeremy Rose, Sarfraz Memon, Daniel F Fowler, Seth M Steinberg, Eva H Baker, Sandya R Pan...> ;Rheumatology. 2022 Aug 3
1 citations
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease.
Ana Zelic Kerep, Filip Pirsl, Seth Steinberg, Sandra Mitchell, Lauren Curtis, Noa Holtzman, Sencer Goklemez, Ervina Bilic, Edward Cowen, Dominique Pichard, Galen Joe, ...> ;Hemasphere. 2022 Jun 1
5 citations
Chemokine receptor CCR9 suppresses the differentiation of CD4CD8ααintraepithelial T cells in the gut.
Can Li, Hye Kyung Kim, Praveen Prakhar, Shunqun Luo, Assiatu Crossman, Davinna L Ligons, Megan A Luckey, Parirokh Awasthi, Ronald E Gress, Jung-Hyun Park> ;Mucosal Immunology. 2022 May 1
2 citations
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obli...
Kirsten M Williams, Steven Z Pavletic, Stephanie J Lee, Paul J Martin, Don E Farthing, Frances T Hakim, Jeremy Rose, Beryl L Manning-Geist, Juan C Gea-Banacloche, Leor...> ;Transplantation and Cellular Therapy. 2022 May 1
7 citations
Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias.
Elisaveta Voynova, Nga Hawk, Francis A Flomerfelt, William G Telford, Ronald E Gress, Jennifer A Kanakry, Damian Kovalovsky> ;Cancers. 2022 Jan 21
11 citations
In vivo availability of the cytokine IL-7 constrains the survival and homeostasis of peripheral iNKT cells.
Joo-Young Park, Hee Yeun Won, Devon T DiPalma, Hye Kyung Kim, Tae-Hyoun Kim, Can Li, Noriko Sato, Changwan Hong, Ninan Abraham, Ronald E Gress, Jung-Hyun Park> ;Cell Reports. 2022 Jan 11
1 citations
Peripheral blood marker of residual acute leukemia after hematopoietic cell transplantation using multi-plex digital droplet PCR.
M Stanojevic, M Grant, S K Vesely, S Knoblach, C G Kanakry, J Nazarian, E Panditharatna, K Panchapakesan, R E Gress, J Holter-Chakrabarty, Kirsten M Williams> ;Frontiers in Immunology. 2022 Jan 1
5 citations
Dynamical Systems Modeling of Early-Term Immune Reconstitution with Different Antithymocyte Globulin Administration Schedules in Allogeneic Stem Cell Transplantation.
Viktoriya Zelikson, Gary Lee Simmons, Natasha Raman, Elizabeth Krieger, Anatevka Rebiero, Kelly G. Hawks, May Aziz, Catherine H. Roberts, Alden Chesney, Jason Reed, Ro...> ;Transplantation and Cellular Therapy. 2021 Oct 21
6 citations
The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic i NKT Cell Generation and NKT1 Subset Differentiation
Hee Yeun Won, Hye Kyung Kim, Assiatu Crossman, Parirokh Awasthi, Ronald E. Gress, Jung-Hyun Park> ;Frontiers in Immunology. 2021 May 14
10 citations
Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia
Damian Kovalovsky, Jeong Heon Yoon, Matthew G. Cyr, Samantha Simon, Elisaveta Voynova, Christoph Rader, Adrian Wiestner, Julie Alejo, Stefania Pittaluga, Ronald E. Gress> ;Leukemia. 2021 Feb 25
19 citations
Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.
Julian C. Assmann, Don E. Farthing, Keita Saito, Natella Maglakelidze, Brittany Oliver, Kathrynne A. Warrick, Carole Sourbier, Christopher J. Ricketts, Thomas J. Meyer...> ;Blood. 2021 Jan 7
9 citations
The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells.
Hilary R. Keller, Hye Kyung Kim, Yuna Jo, Ronald E. Gress, Changwan Hong, Jung-Hyun Park> ;Journal of Immunology. 2020 Jun 15
5 citations
90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained...
Kevin C. Conlon, Claude Sportes, Martin W. Brechbiel, Daniel H. Fowler, Ronald E. Gress, Milos D. Miljkovic, Clara C. Chen, Millie Whatley, Bonita R. Bryant, Erin M Co...> ;Cancer Biotherapy & Radiopharmaceuticals. 2020 May 13
15 citations
Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.
Pamela Stratton, Minoo Battiwalla, Xin Tian, Suzanne Abdelazim, Kristin Baird, A. John Barrett, Caroline R. Cantilena, Richard W. Childs, Jessica DeJesus, Courtney D. ...> ;JAMA Oncology. 2020 May 1
Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Jennifer N. Brudno, Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John J. Rossi, Allen Xue, Adrian Bot, Nathalie Scholler, Lekha Mikkilineni, Mark Rosch...> ;Nature Medicine. 2020 May 1
156 citations
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
Jennifer N. Brudno, Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John J. Rossi, Allen Xue, Adrian Bot, Nathalie Scholler, Lekha Mikkilineni, Mark Rosch...> ;Nature Medicine. 2020 Jan 20
21 citations
Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases
Dimana Dimitrova, Juan Gea-Banacloche, Seth M. Steinberg, Jennifer L. Sadler, Stephanie N. Hicks, Ellen Carroll, Jennifer S. Wilder, Mark Parta, Lauren R. Skeffington,...> ;Biology of Blood and Marrow Transplantation. 2020 Jan 1
140 citations
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
Lucas P. Wachsmuth, Michael T. Patterson, Michael Eckhaus, David Venzon, Ronald E. Gress, Christopher G. Kanakry> ;The Journal of Clinical Investigation. 2019 Jun 3
5 citations
Differential Cytokine Utilization and Tissue Tropism Results in Distinct Repopulation Kinetics of Naïve vs. Memory T Cells in Mice.
Hye Kyung Kim, Hyunsoo Chung, Juntae Kwon, Ehydel Castro, Christopher Johns, Nga V. Hawk, SuJin Hwang, Jung-Hyun Park, Ronald E. Gress> ;Frontiers in Immunology. 2019 Mar 4
11 citations
Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
Ana Zelic Kerep, Jacob Broome, Filip Pirsl, Lauren M. Curtis, Seth M. Steinberg, Sandra A. Mitchell, Edward W. Cowen, Dominique C. Pichard, Galen O. Joe, Leora E. Comi...> ;Bone Marrow Transplantation. 2019 Jan 1
28 citations
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach...
Ricardo J. Melendez-Munoz, Rachel Marchalik, Theresa Jerussi, Dimana Dimitrova, Veronique Nussenblatt, Andrea Beri, Khalid Rai, Jennifer S. Wilder, A. John Barrett, Mi...> ;Biology of Blood and Marrow Transplantation. 2018 Mar 1
480 citations
T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
Jennifer N. Brudno, Irina Maric, Steven Hartman, Jeremy J. Rose, Michael Wang, Norris Lam, Maryalice Stetler-Stevenson, Dalia A. Salem, Constance M. Yuan, Steven Z. Pa...> ;Journal of Clinical Oncology. 2018 May 29
11 citations
Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study
, , , , , , , , , , , , , , , , , > ;The Lancet. Haematology. 2018 Jan 1
Join now to see all

Journal Articles

Impact of the 2014 NIH Chronic Graft-Versus-Host Disease Scoring Criteria Modifications Assessed in a Large Cohort of Severely Affected Patients
Lauren M Curtis, Galen O Joe, Jacqueline W Mays, Ann Berger, Pamela Stratton, Ronald E Gress, Sandra A Mitchell, Steven Z Pavletic, Kristin Baird, Nature

Abstracts/Posters

T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions ...
Ronald E. Gress, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Grant Support

Etib Clinical TrialsNational Cancer Institute2011
Etib Clinical Research CoreNational Cancer Institute2011
Transplant ModelsNational Cancer Institute2010–2011
Immune ReconstitutionNational Cancer Institute2010–2011
Clinical TrialsNational Cancer Institute2010
Branch Clinical Research CoreNational Cancer Institute2010
Transplant ModelsDivision Of Basic Sciences - Nci2009
Immune ReconstitutionDivision Of Basic Sciences - Nci2009
Clinical TrialsDivision Of Basic Sciences - Nci2009
Branch Clinical Research CoreDivision Of Basic Sciences - Nci2009
Transplant ModelsNational Cancer Institute2008
Clinical TrialsNational Cancer Institute2008
Branch Clinical Research CoreNational Cancer Institute2008
Immune ReconstitutionNational Cancer Institute2007–2008
Immune ReconstitutionDivision Of Basic Sciences - Nci2003–2006
Hematopoietic Stem Cell Gene Therapy For LADDivision Of Clinical Sciences - Nci2001

Hospital Affiliations

NIH Clinical CenterBethesda, Maryland